Practice parameter for the diagnosis and management of primary immunodeficiency

详细信息    查看全文

• 作者：Francisco A. Bonilla ; MD ; PhD ; ^{francisco.bonilla@childrens.harvard.edu" class="auth_mail" title="E-mail the corresponding author} ; David A. Khan ; MD ; Zuhair K. Ballas ; MD ; Javier Chinen ; MD ; PhD ; Michael M. Frank ; MD ; Joyce T. Hsu ; MD ; Michael Keller ; MD ; Lisa J. Kobrynski ; MD ; Hirsh D. Komarow ; MD ; Bruce Mazer ; MD ; Robert P. Nelson Jr. ; MD ; Jordan S. Orange ; MD ; PhD ; John M. Routes ; MD ; William T. Shearer ; MD ; PhD ; Ricardo U. Sorensen ; MD ; James W. Verbsky ; MD ; PhD ; David I. Bernstein ; MD ; Joann Blessing-Moore ; MD ; David Lang ; MD ; Richard A. Nicklas ; MD ; John Oppenheimer ; MD ; Jay M. Portnoy ; MD ; Christopher R. Randolph ; MD ; Diane Schuller ; MD ; Sheldon L. Spector ; MD ; Stephen Tilles ; MD ; Dana Wallace ; MD
• 关键词：AAAAI ; American Academy of Allergy ; Asthma & Immunology ; ACAAI ; American College of Allergy ; Asthma & Immunology ; HSCT ; Hematopoietic stem cell therapy ; JCAAI ; Joint Council of Allergy ; Asthma & Immunology ; PIDD ; Primary immunodeficiency disease ; SCID ; Severe combined immunodeficiency ; SS ; Summary statement
• 刊名：Journal of Allergy and Clinical Immunology
• 出版年：2015
• 出版时间：November 2015
• 年：2015
• 卷：136
• 期：5
• 页码：1186-1205.e78
• 全文大小：2526 K

文摘

The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology (ACAAI) have jointly accepted responsibility for establishing the “Practice parameter for the diagnosis and management of primary immunodeficiency.” This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.